Forbes -
15 Apr 2015 04:33
Chinese e-commerce titan Alibaba Group Holding will inject its online-pharmacy business into the company’s Hong Kong-listed healthcare arm in a HK $ 19.4 billion deal($ 2.5 billion), as the group seeks new opportunities in China’s fast growing healthcare sector.
Share this Article
Comment on this Article
Please to comment